Circulating Tumor Cells in Perioperative Esophageal Cancer Patients: Quantitative Assay System and Potential Clinical Utility
Open Access
- 15 May 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (10) , 2992-2997
- https://doi.org/10.1158/1078-0432.ccr-06-2072
Abstract
Purpose: To establish a quantitative system for evaluating the role of circulating tumor cells (CTC) in peripheral blood samples in patients who undergo surgery for treatment of esophageal cancer.Keywords
This publication has 29 references indexed in Scilit:
- Carcinoembryonic Antigen Messenger RNA Expression in Blood Predicts Recurrence in Esophageal CancerClinical Cancer Research, 2006
- Real‐time RT‐PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinomaInternational Journal of Cancer, 2005
- Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast CancerJournal of Clinical Oncology, 2005
- The Use of Real-Time Reverse Transcription-PCR for Prostate-Specific Antigen mRNA to Discriminate between Blood Samples from Healthy Volunteers and from Patients with Metastatic Prostate CancerClinical Cancer Research, 2004
- Detection of circulating oesophageal squamous cancer cells in peripheral blood and its impact on prognosisBritish Journal of Surgery, 2004
- Dissecting the metastatic cascadeNature Reviews Cancer, 2004
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Circulating Breast Cancer Cells Are Frequently ApoptoticThe American Journal of Pathology, 2001
- Haematogenous dissemination of prostatic epithelial cells during radical prostatectomyThe Lancet, 1995